NAV
$48.86
AUM
$117.1M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.92
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +7.53% | +2.44% | +6.69% | +16.55% | +17.07% | +8.96% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 3.93% |
| 2 | FMEDM26 | MSCI Europe Net Total Return Future June 26 | 1.95% |
| 3 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.90% |
| 4 | NOVN.SW | Novartis AG Registered Shares | 1.85% |
| 5 | HSBA.L | HSBC Holdings PLC | 1.84% |
| 6 | AZN.L | AstraZeneca PLC | 1.70% |
| 7 | FTOXX | Goldman Sachs FS Treasury Obligs Instl | 1.65% |
| 8 | SAN.MC | Banco Santander SA | 1.31% |
| 9 | SHEL.L | Shell PLC | 1.30% |
| 10 | SIE.DE | Siemens AG | 1.22% |
The index is designed to deliver exposure to equity securities of developed markets issuers in Europe. The fund seeks to achieve its investment objective by investing at least 80% of its assets (exclusive of collateral held from securities lending) in securities included in its underlying index, in depositary receipts representing securities included in its underlying index and in underlying stocks in respect of depositary receipts included in its underlying index.
Inception Date: 2016-03-02